DeAnna Baker Frost, MD, PhD
Assistant Professor
Medical University of South Carolina
Charleston, South Carolina, United States
Disclosure(s): Allogene: Consultant (Ongoing); Boehringer-Ingelheim: Consultant (Ongoing)
Arissa Young, MD
UCLA
Los Angeles, California, United States
Disclosure(s): No financial relationships with ineligible companies to disclose
DeAnna Baker Frost, MD, PhD
Assistant Professor
Medical University of South Carolina
Charleston, South Carolina, United States
Disclosure(s): Allogene: Consultant (Ongoing); Boehringer-Ingelheim: Consultant (Ongoing)
Elizabeth Volkmann, MD, MS
Associate Professor, Division of Rheumatology
University of California, Los Angeles
Los Angeles, California, United States
Disclosure(s): AbbVie/Abbott: Consultant (Ongoing); AstraZeneca: Grant/Research Support (Ongoing); Atyr Pharma: Grant/Research Support (Ongoing); Boehringer-Ingelheim: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); GlaxoSmithKlein(GSK): Consultant (Ongoing), Grant/Research Support (Ongoing); Horizon: Grant/Research Support (Ongoing); Kadmon: Grant/Research Support (Ongoing); Prometheus: Grant/Research Support (Ongoing)
This session will feature two internationally recognized experts in Raynaud's phenomenon and capillaroscopy. Raynaud's phenomenon affects many patients with autoimmune rheumatic diseases, and treatment options are limited. This session will help the learner appreciate the different methods for assessing nailfold capillary changes in the clinic and understanding their implications for clinical care. This session will also review existing and emerging therapies for both Raynaud's phenomenon and digital ulcers
Speaker: Tracy Frech, MD, MS – Vanderbilt University Medical Center
Speaker: John Pauling, PhD, BSc, FRCP, MBBCH – North Bristol NHS Trust